Showing results (1101-1110 of 1,243) with videos related to

Sort By:
Pageof 125
Plos One|September 12, 2013
Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL)Manikhandan A V Mudaliar, Ross D Haggart, Gino Miele, et al.
The Journal of Bone and Joint Surgery. American Volume|November 5, 2020
The Optimal Dosing Regimen for Tranexamic Acid in Revision Total Hip Arthroplasty: A Multicenter Randomized Clinical TrialRobert A Sershon, Yale A Fillingham, Matthew P Abdel, et al.
Cancer Chemotherapy and Pharmacology|August 13, 2002
STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trialDavid M Vail, Ilene D Kurzman, Phyllis C Glawe, et al.
Journal of Neurosurgery|March 17, 2017
Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Stroke|March 24, 2018
SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 TrialCraig J Smith, Sharon Hulme, Andy Vail, et al.
Cell Reports|March 2, 2022
CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilitiesErik S Knudsen, Vishnu Kumarasamy, Ram Nambiar, et al.
JAMA Network Open|June 25, 2024
Lung Donation and Transplant Recipient Outcomes at Independent vs Hospital-Based Donor Care UnitsEmily A Vail, Xingmei Wang, Douglas E Schaubel, et al.
Cancers|September 28, 2023
Inhibition of EphA3 Expression in Tumour Stromal Cells Suppresses Tumour Growth and ProgressionMary E Vail, Rae H Farnsworth, Linda Hii, et al.
Clinics and Practice|September 22, 2022
PD-L1 Over-Expression Varies in Different Subtypes of Lung Cancer: Will This Affect Future Therapies?Asad Ullah, Steven Pulliam, Nabin Raj Karki, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Safety and Feasibility of Infusing Ex Vivo Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid TumorsAllison M Weisnicht, Fernanda Szewc, Monica Moonkyung Cho, et al.
Pageof 125